Detalhe da pesquisa
1.
Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.
Immunity
; 57(4): 890-903.e6, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518779
2.
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
PLoS Pathog
; 18(1): e1010179, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990486
3.
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.
J Virol
; 93(14)2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068427
4.
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
Front Immunol
; 14: 1135841, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033983
5.
Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
Front Immunol
; 14: 1201033, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180140
6.
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
Sci Transl Med
; 15(716): eadg3540, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792954
7.
Durable SARS-CoV-2 B cell immunity after mild or severe disease.
J Clin Invest
; 131(7)2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571162
8.
Durable SARS-CoV-2 B cell immunity after mild or severe disease.
medRxiv
; 2020 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140070